For those who meet the criteria of being overweight (a BMI of 25 or higher) or obese (a BMI of 30 or higher), Semaglutide can be a game changer
Figure 5 Table 2 Therapeutic strategies targeting immune cell mitochondria
Often a clinician at the point of care will come to us with a hunch Ive seen a bunch of these The GLP-1 wave keeps widening Semaglutide hits the GLP-1 receptor alone, tirzepatide adds a second in GIP, and next-generation candidates layer on a third in glucagon or drop incretins altogether for amylin and FGF21 biology
Compounded and Brand-Name Options For patients who want or require FDA-approved branded medications Ivy RX also facilitates access to Ozempic and Mounjaro
Cappelletti, S., Daria, P., Sani, G., & Aromatario, M